Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study.
about
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.New directions in natural killer cell-based immunotherapy of human cancer.IL2 treatment for cancer: from biology to gene therapyNatural killer cells: can they be useful as adoptive immunotherapy for cancer?Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?Is there a place for immunotherapy with interleukin-2 to prevent relapse after autologous stem cell transplantation for acute leukemia?Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases.Chronic myeloid leukemia as an immunological target.Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.
P2860
Q33380148-8348F9D5-2E17-4644-98FE-C7EBC62C2C10Q34557233-F69A4673-EBF4-4F0E-AE44-B03B51011F20Q35093608-2A08FBC6-C948-407D-A839-E28A85397221Q35565971-FF8C2FA1-48FD-44CD-92DA-A2165B230407Q36065944-D1C85DC2-E698-4747-9F4D-BF4FF4F6E034Q39205106-D803D35D-9777-4FDA-B216-0C60DBC9DDB1Q40548689-AB9E0AB0-C474-4940-9B06-009B26127C31Q40668598-947AA5DA-D17E-460E-8112-465458931E14Q40916271-064B77CC-22A2-4B54-9FEB-9FE445E4C3E4Q40958122-A0EDDD21-2F28-4E2E-B944-D8E3C9412DF6Q54110984-C1F7FF4D-E27E-4EF9-ADE7-E5CE400D248AQ54139435-687F645A-6EFF-4A58-B839-6578F2FB7080
P2860
Continuous intravenous infusion of high-dose recombinant interleukin-2 for acute myeloid leukaemia--a phase II study.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Continuous intravenous infusio ...... d leukaemia--a phase II study.
@en
type
label
Continuous intravenous infusio ...... d leukaemia--a phase II study.
@en
prefLabel
Continuous intravenous infusio ...... d leukaemia--a phase II study.
@en
P2093
P356
P1476
Continuous intravenous infusio ...... d leukaemia--a phase II study.
@en
P2093
A C Newland
A H Goldstone
D Bareford
E Offerman
P2888
P304
P356
10.1007/BF01741555
P577
1992-01-01T00:00:00Z
P6179
1023171844